AI Isn't Just for Code—It's Designing the Future of RNA Therapies
The success of RNA vaccines during the COVID-19 pandemic was a monumental scientific achievement. But it also highlighted a critical bottleneck: designing the delivery vehicle is as important as designing the RNA sequence itself. The process of creating the right lipid nanoparticles (LNPs) to protect and deliver RNA into our cells has been a slow, resource-intensive process of trial and error. New research from MIT, however, shows how AI is poised to break this bottleneck for good. ...